InsiderTrades.com logo
Tim Sykes’ Urgent Trade Alert: “Make this move now”
From Timothy Sykes   |   Ad
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
Click here to see a unique election-year trade

ZBIO Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $46,751,339.00
Insider Selling (Last 12 Months): $0.00

ProShares UltraPro Short Nasdaq Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at ProShares UltraPro Short Nasdaq Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ProShares UltraPro Short Nasdaq Biotechnology Share Price & Price History

Current Price: $19.95
Price Change: ▼ Price Decrease of -0.52 (-2.54%)
As of 11/4/2024 01:00 AM ET

This chart shows the closing price history over time for ZBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
A new way to play the AI boom (act before November 19)
From Behind the Markets   |   Ad
There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as little as $16 and a brokerage account.
Click here to get the ticker >>>

ProShares UltraPro Short Nasdaq Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/20/2024Leon O Moulder JrCEOBuy5,000$18.45$92,250.001,672,039View SEC Filing Icon  
9/18/2024Leon O Moulder JrCEOBuy10,000$17.91$179,100.001,662,039View SEC Filing Icon  
9/16/2024Patrick G EnrightDirectorBuy440,000$17.00$7,480,000.00774,530View SEC Filing Icon  
9/16/2024Sr One Capital Management, LlcMajor ShareholderBuy2,235,294$17.00$37,999,998.001,946,564View SEC Filing Icon  
9/13/2024Hongbo LuDirectorBuy58,823$17.00$999,991.0058,823View SEC Filing Icon  
See Full Table
Watch this before it gets removed
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO)

Zenas BioPharma Inc. is a clinical-stage global biopharmaceutical company. It involved in the development and commercialization of transformative immunology-based therapies for patients in need. The company's lead product candidate includes obexelimab and Fc?RIIb. Zenas BioPharma Inc. is based in WALTHAM, Mass.
Read More on ProShares UltraPro Short Nasdaq Biotechnology

Today's Range

Now: $19.95
Low: $19.40
High: $21.10

50 Day Range

MA: $10.05
Low: $10.02
High: $10.09

52 Week Range

Now: $19.95
Low: $8.28
High: $18.64

Volume

57,340 shs

Average Volume

156,415 shs

Market Capitalization

$793.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ProShares UltraPro Short Nasdaq Biotechnology?

ProShares UltraPro Short Nasdaq Biotechnology's top insider investors include:
  1. Sr One Capital Management, Llc (Major Shareholder)
  2. Leon O Moulder Jr (CEO)
  3. Patrick G Enright (Director)
  4. Hongbo Lu (Director)
Learn More about top insider investors at ProShares UltraPro Short Nasdaq Biotechnology.
Tim Sykes’ Urgent Trade Alert: “Make this move now”
From Timothy Sykes   |   Ad
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
Click here to see a unique election-year trade